tirzepatide health canada Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Benefits of Tirzepatide Injections |

(Weight loss even without GLP-1 medication results in some loss of muscle.) This is of particular concern for older adults, who may be at a higher risk for frailty and falls

Symptoms observed in the newborn period include poor feeding and weight gain

The FDA has approved Wegovy and Zepbound for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Think long-term: View your GLP-1 medication as an aid, not the main component

When you start Tirzepatide, your provider will monitor your progress, adjust your dose if needed, and help you incorporate sustainable lifestyle changes for long-term success